The title compounds 6a-j, 2-[(6-methyl-1,3-benzothiazol-2-yl)amino]-N-[2-(substituted phenyl/furan-2-yl)-4-oxo-1,3-thiazolidin-3-yl]nicotinamides, were prepared from 2-chloropyridine-3-carboxylic acid (1) and 2-amino-6-methylbenzothiazole (2) by known methods. All the compounds have been established by IR, 1 H NMR, 13 C NMR and elemental analyses. The in vitro antimicrobial screening of the compounds were carried out against two Gram positive (S. aureus, S. pyogenes), two Gram negative (E. coli, P. aeruginosa) bacteria and three fungal species (C. albicans, A. niger, A. clavatus) using the broth microdilution method. Some of the compounds are comparable with standard drugs.
Introduction
A large number of drugs and biologically relevant molecules contain heterocyclic systems. Often the presence of hetero atoms or groupings imparts preferential specificities in their biological responses. The chemistry and biological study of heterocyclic compounds has been interesting field for a long time due to medicinal and agricultural reasons. The number of heterocyclic derivatives containing nitrogen and sulfur atom possess broad spectrum of biological activities. One of the most important heterocycle in medicinal chemistry is pyridine with wide application including antimicrobial, anti-inflammatory, anti-HIV, antiplasmodial, anti-tubercular, antibacterial and anticonvulsant [1] [2] [3] [4] [5] [6] [7] activities, and has much other important biological significance. The 4-thiazolidinone ring system comprises the broad spectrum for a number of biologically active compounds. In recent years, 4-thiazolidinones are the most extensively investigated class of compounds, which exhibit various biological activities, such as antimicrobial, anti-inflammatory, anti-HIV, anti-toxoplasma gondii and analgesic [8] [9] [10] [11] [12] .
Looking towards literature, it was thought that incorporation of all these biologically active moieties might be result in better antimicrobial activity and therefore as the part of our continuous research in developing the new heterocycles containing nitrogen and sulfur atom and screening their microbial studies [13] [14] [15] , herewith we have designed 4-thiazolidinones incorporated nicotinic acid with 2-amino-6-methylbenzothiazole and examined their antimicrobial activities.
Results and Discussion

Synthesis of compounds
2-Chloro pyridine-3-carboxylic acid 1 and 2-amino-6-methyl benzothiazole 2 in presence of anhydrous K 2 CO 3 and Cu-bronze in DMF solvent on Ullmann condensation yielded 2-[(6-methyl-2-benzothiazolyl)amino]nicotinic acid (3) . Further heating 3 with SOCl 2 and subsequent reaction with hydrazine hydrate in chloroform formed 4 which on condensation with substituted aromatic aldehydes in DMF gave 5a-j. Thaizolidinones 6a-j were synthesized by refluxing 5a-j and thioglycolic acid in dry 1,4-dioxane for 12-14 h using a Dean-Stark apparatus (Scheme 1). Purity of the compounds was checked by TLC using ethyl acetate: toluene (1:3) as a solvent system. Structures were characterized by spectral data (FT-IR, 1 H-NMR and 13 C-NMR).
Investigations, Results and Discussion
The in vitro antibacterial and antifungal activities of the compounds are shown in Table 1 . The MICs (μg/ml) were carried out by broth microdilution method as described by Rattan [17] .
Antibacterial Activity
From the screening results (Table 1) , it is evident that compound 1 displayed good to moderate activity against all bacteria (150-250 μg/ml). 2-Amino-6-methylbenzothiazole (2), compound 3 and hydrazide 4 exhibited moderate to poor activity against all bacteria.
The result shows that compounds 5a, 5e, 5j, 6d, 6g and 6j exhibited good activity (25-100 μg/ml) against E. coli; 5d, 5j, 6d, 6i and 6j exhibited good activity (50-100 μg/ml) against P. aeruginosa; 5a, 5e, 5f, 5h, 5j, 6d, 6b and 6j showed good to very good activity (25-150 μg/ml) against S. aureus; whereas 5b, 5h, 5j, 6c, 6i and 6j showed good activity (62.5-100 μg/ml) against S. pyogenes compared with ampicillin. All other compounds showed moderate activity.
Antifungal Activity
From the results of the antifungal activity (Table 1) , it is evident that compounds 1, 2, 3 and 4 showed good to moderate activity against C. albicans. 500 100 1000 100 >1000 500 >1000 6j 100 62.5 25 100 500 1000 1000 Ampicillin 100 100 250 100 ---Griseofulvin ----500 100 100
Conclusion
Most of the compounds are comparable with ampicillin. Compounds bearing -Cl, -NO 2 groups and furan nucleus are more active than the remaining compounds. Compounds 5a, 5d, 5g, 5j, 6b, 6e, 6f and 6j were found to be active against C. albicans but they found poor with other fungal species.
Experimental
All chemicals were of analytical grade and used directly. Melting points of the synthesized compounds were determined by open tube capillary method and were uncorrected. The purity of the compounds was checked by TLC using Merck silica gel 60 F 254 . IR spectra were recorded on a Perkin-Elmer RX 1 FTIR spectrophotometer, using potassium bromide pellets; the frequencies are expressed in cm −1 . The 1 H NMR and 13 C NMR spectra were recorded with a Bruker Avance II 400 NMR spectrometer, using TMS as an internal reference, with DMSO-d 6 as solvent. The chemical shifts are reported in parts per million (δ ppm). Elemental analyses were performed on Carlo Erba 1180 CHN analyzer. All the results of elemental analyses were in an acceptable error range.
2-Amino-6-methylbenzothiazole (2), 2-[(6-methyl-1,3-benzothiazol-2-yl)amino]nicotinic acid (3) and 2-[(6-methyl-1,3-benzothiazol-2-yl)amino]nicotinohydrazide (4) were prepared by reported procedures [15, 16] . Benzaldehyde (0.012 mole, 1.272 g) and 3-4 drops of glacial acetic acid were added to a solution of 4 (0.01 mole, 3.0 g) in DMF (30 mL). The reaction mixture was refluxed for 5-6 h and monitored by TLC on silica gel using ethyl acetate:toluene (1:3). The reaction mass was cooled and poured onto crushed ice and thus the separated solid was isolated, washed with water and recrystallized from ethanol to give 5a. Other derivatives 5b-j were prepared by the same method.
Fig. 1.
Numbering
White solid, yield: 52 %, mp: 180-182 °C. IR (KBr) ν cm 32 (s, 1H, H-25), 5.84 (s, 1H, H-8), 6.82-8.56 (m, 8H, H-4,5,6,11,13,14,19,23), 8.87 (s, 1H, H-7), 9.37 (s, 1H, H-17) . 13 A mixture of 5a (0.01 mole, 3.87 g), thioglycolic acid (0.015 mole, 1.38 g) and a pinch of anhydrous ZnCl 2 in dry 1,4-dioxane (30 mL) was refluxed for 12-14 h. The reaction was monitored by TLC on silica gel using ethyl acetate: toluene (1:3); was cooled and neutralized with 10% sodium bicarbonate solution. The solid product separated was filtered, washed with water and recrystallized from ethanol to give 6a. Similarly, other 2-[(6-methyl-1,3-benzothiazol-2-yl)amino]-N-[2-(substituted phenyl/furan-2-yl)-4-oxo-1,3-thiazolidin-3-yl]pyridine-3-carboxamides 6b-j have been prepared by the same method.
2-[(6-Methyl-1,3-benzothiazol-2-yl)amino]-N'-(2-nitrobenzylidene)pyridine-3-carbohydrazide (5d)
N'-(4-Hydroxy-3-methoxy-5-nitrobenzylidene)-2-[(6-methyl-1,3-benzothiazol-2-yl)amino]pyridine-3-carbohydrazide (5i)
Fig. 2.
Numbering of 4-Thiazolidinones 6a-j 24 (s, 3H, H-18), 3.63 (s, 2H, H-9), 6.21 (s, 1H, H-10), 6.91-8.57 (m, 11H, H-4,5,6,13,15,16,21,22,23,24,25), 8.91 (s, 1H, H-7), 9.36 (s, 1H,  H-19) . 13 C NMR (100MHz, DMSO-d 6 , TMS): δ 21.1 (C-18), 35.9 (C-9), 57.7 (C-10), 111.6 (C-3), 114.1 (C-16), 118.5 (C-5), 121.1 (C-13), 125.9 (C-15), 127.1 (C-22,24), 128.1 (C-21,25), 129.9 (C-12), 134.4 (C-14) , 137.0 (C-4), 138.1 (C-20), 147.4 (C-6), 149.1 (C-17) 
2-[(6-Methyl-1,3-benzothiazol-2-yl)amino]-N-(4-oxo-2-phenyl-1,3-thiazolidin-3-yl)pyridine-3-carboxamide (6a)
2-[(6-Methyl-1,3-benzothiazol-2-yl)amino]-N-[2-(2-nitrophenyl)-4-oxo-1,3-thiazolidin-3-yl]pyridine-3-carboxamide (6d)
Experimental protocol for Antimicrobial activity
All the compounds were tested for their antibacterial and antifungal activity (MIC) in vitro by broth dilution method against two Gram positive S. aureus MTCC 96, S. pyogenes MTCC 442 and two Gram negative E. coli MTCC 443, P. aeruginosa MTCC 741 bacteria and three fungal species C. albicans MTCC 227, A. niger MTCC 282 and A. clavatus MTCC 1323. Ampicillin for antibacterial activity while griseofulvin for antifungal activity were used as a standard drug
The experimental protocol followed for antimicrobial activity was according to the same method as previously reported in literature [18, 19] .
